Signaling Pathways - MER - MDM2 - AdipoR1 - RET
清除全部
-
B8016 UNC20251 CitationTarget: MER|FLT3Summary: 口服生物可利用的双重MER/FLT3抑制剂 -
B1879 AdipoRonTarget: AdipoR1|AdipoR2Summary: AdipoR1/2激动剂 -
A2174 Lenvatinib (E7080)中文名: 乐伐替尼，仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂 -
A8236 Regorafenib4 Citation中文名: 瑞戈非尼Target: Raf|VEGFR|PDGFR|c-Kit|RETSummary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂 -
A3762 RG71125 CitationTarget: MDM2Summary: MDM2抑制剂 -
A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂 -
A4228 Nutlin-3Target: MDM2Summary: MDM2 拮抗剂 -
A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Aurora A/Flt3的选择性抑制剂 -
N1315 Parthenolide中文名: 小白菊内酯，欧苷菊Target: Histone Deacetylases (HDACs)|MDM2|DNA Methyltransferases|p53|5-HT